Large Variation in Provincial Guidelines for Urine Drug Screening During Opioid Agonist Treatment in Canada

Files in This Item:
Access to this item has been restricted by the copyright holder until:2019-06-01
File Description SizeFormat 
UDS editorial edited_Feb14.pdf126.96 kBAdobe PDFDownload    Request a copy
Title: Large Variation in Provincial Guidelines for Urine Drug Screening During Opioid Agonist Treatment in Canada
Authors: Moss, Eloise
McEachern, Jasmine
Adye-White, Lauren
Cullen, Walter
Klimas, Jan
et al.
Permanent link: http://hdl.handle.net/10197/10074
Date: Jun-2018
Online since: 2019-04-23T11:03:16Z
Abstract: Urine drug screening (UDS) is commonly used to detect or validate self-reported substance use, particularly when beginning and maintaining opioid agonist therapy. However, there is currently no summary of the published clinical practice guidelines for UDS in Canada, and no measure of the consistency with which different provinces suggest administering UDS. Therefore, we conducted a policy scan of UDS guidelines, examining the published clinical practice guidelines for each Canadian province and extracting all relevant data in March 2017. Our Canadian guideline and policy scan found that UDS frequency recommendations vary greatly among Provinces for persons receiving opioid agonist therapy for opioid use disorder.
Type of material: Journal Article
Publisher: Wolters Klumer
Journal: Canadian Journal of Addiction
Volume: 9
Issue: 2
Start page: 6
End page: 9
Copyright (published version): 2018 by Lippincott Williams & Wilkins
Keywords: GuidelinesOpioid agonist therapyCanadian guideline and policy scanUrine drug screening
DOI: 10.1097/CXA.0000000000000015
Language: en
Status of Item: Peer reviewed
Appears in Collections:Medicine Research Collection

Show full item record

SCOPUSTM   
Citations 50

1
Last Week
0
Last month
checked on May 24, 2019

Google ScholarTM

Check

Altmetric


This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.